
    
      Participants will be randomized in a 1:1 ratio to receive either Adacel or Boostrix vaccine.

      Subjects will be monitored for immediate reactions for 15 minutes post-vaccination.
      Unsolicited adverse events and serious adverse events will be collected from Visit 1 through
      Visit 2.
    
  